Lung Cancer - Advancements in Treatment, Early Detection and Research

Service: Topics: Organization:
Long Beach Memorial
Featured speaker:

Robert A. Nagourney, MD

Specialties:
  • Oncology - Medical, Oncology & Hematology, Internal Medicine

Robert A. Nagourney, MD, is Medical and Laboratory Director at Rational Therapeutics, Inc., in Long Beach, California and teaches Pharmacology at the University of California at Irvine. He is board certified in internal medicine, medical oncology, and hematology. He has licensure in California and Virginia.

A native of Bridgeport, Connecticut, Dr. Nagourney completed his undergraduate education at Boston University, Massachusetts, earning a BA in Chemistry, graduating Summa Cum Laude with Distinction in Biochemistry. Dr. Nagourney went on to receive his MD at McGill University in Canada, where he was a University Scholar. He then completed his Residency in Internal Medicine at the University of California, Irvine, and the Long Beach VA Medical Center. Dr. Nagourney completed his Fellowship in Medical Oncology at Georgetown University Hospital in Washington, DC. As a recipient of the Scripps Institute Young Investigator Award, he completed further study in Hematology at Scripps Clinic and Research Institute in La Jolla, California.

Dr. Nagourney's focus on the laboratory study of cancer cell death events (apoptosis) has provided a robust method for the prediction of patient's response and survival in the clinical setting. The initial application of this process was in the study of existing cytotoxic drugs and radiation effects on human cancer cells. As clinical correlations became increasingly strong, the laboratory tests are now also applied to the study of novel drugs and combinations. Dr. Nagourney has over 20 years experience studying human tissue cultures. He has authored over 100 manuscripts and abstracts, to include publication in Cancer Research, the British Journal of Cancer, the Journal of The National Cancer Institute, the Journal of Clinical Oncology, Gynecological Oncology and Oncology. He is a co-investigator on national GOG trials. Dr. Nagourney is a frequently invited lecturer for a variety of professional organizations and universities. He serves on several editorial boards and reviews numerous professional journals to include Clinical Cancer Research, British Journal of Cancer, Gynecologic Oncology, Oncology Research and Journal of Medicinal Food.

Podcast Summary

Lung cancer has the highest mortality rate of any cancer, largely because it is rarely detected early, resulting in late stage diagnosis of the disease, making it more difficult to treat.

Dr. Robert Nagourney, MD discusses the great need to raise awareness and explains the signs and symptoms of lung cancer and early detection.